118 related articles for article (PubMed ID: 20349754)
21. ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life.
Lindén VB; Lidegran MK; Frisén G; Dahlgren P; Frenckner BP; Larsen F
Acta Anaesthesiol Scand; 2009 Apr; 53(4):489-95. PubMed ID: 19226296
[TBL] [Abstract][Full Text] [Related]
22. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
[TBL] [Abstract][Full Text] [Related]
23. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Harries AD; Gausi F; Chimzizi R; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
[TBL] [Abstract][Full Text] [Related]
25. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings.
Harries AD; Banda HT; Boeree MJ; Welby S; Wirima JJ; Subramanyam VR; Maher D; Nunn P
Int J Tuberc Lung Dis; 1998 Dec; 2(12):999-1004. PubMed ID: 9869116
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with a clinician's decision to stop anti-tuberculosis treatment before completion.
Chiang CY; Enarson DA; Bai KJ; Suo J; Wu YC; Lin TP; Luh KT
Int J Tuberc Lung Dis; 2008 Apr; 12(4):441-6. PubMed ID: 18371272
[TBL] [Abstract][Full Text] [Related]
27. Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico.
Nájera-Ortiz JC; Sánchez-Pérez HJ; Ochoa-Díaz H; Arana-Cedeño M; Lezama MS; Mateo MM
Int J Epidemiol; 2008 Aug; 37(4):786-95. PubMed ID: 18511492
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia.
Chheng P; Tamhane A; Natpratan C; Tan V; Lay V; Sar B; Kimerling ME
Int J Tuberc Lung Dis; 2008 Mar; 12(3 Suppl 1):54-62. PubMed ID: 18302824
[TBL] [Abstract][Full Text] [Related]
29. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.
Singla R; Khan N; Al-Sharif N; Ai-Sayegh MO; Shaikh MA; Osman MM
Int J Tuberc Lung Dis; 2006 Jan; 10(1):74-9. PubMed ID: 16466041
[TBL] [Abstract][Full Text] [Related]
30. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.
Harries AD; Maher D; Nunn P
Bull World Health Organ; 1998; 76(6):651-62. PubMed ID: 10191561
[TBL] [Abstract][Full Text] [Related]
31. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
[TBL] [Abstract][Full Text] [Related]
32. [The significance of health related quality of life for the evaluation of interventional measures in patients with COPD].
Würtemberger G; Hütter BO
Pneumologie; 2001 Feb; 55(2):91-9. PubMed ID: 11268890
[TBL] [Abstract][Full Text] [Related]
33. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
34. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ; Perng RP
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
[TBL] [Abstract][Full Text] [Related]
35. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico.
Sánchez-Pérez HJ; Díaz-Vázquez A; Nájera-Ortiz JC; Balandrano S; Martín-Mateo M
Int J Tuberc Lung Dis; 2010 Jan; 14(1):34-9. PubMed ID: 20003692
[TBL] [Abstract][Full Text] [Related]
37. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
38. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
40. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
